Join PER® September 15th for the New York Advanced Practice Collaborative Meeting! Directed toward NP/PAs, this meeting blends presentations on cutting-edge information with panel discussions to enhance learning.

General Discussions

израиль знакомства

?????????? ? ??????? ????????? ????????? ????? ????????? ?? ??????

For Patients With Lung Cancer, New Therapies Offer Reason to Hope

Betsy Hullender Quinn, MSN, MA, RN, OCN This year has seen an array of new therapies for people with lung cancer. FDA approval of two immunotherapies to treat non-small cell lung cancer (NS...

Breaking Down Walls in Healthcare

Reaching outside your comfort zone can be empowering and satisfying. I’m a nurse entrepreneur. Over the past year, I wrote a book called Navigating the C: A Nurse Charts the Course for Cancer...

Халява налетайте!

?????! ????? ????????????? ??????

Legacy Letters: A Nurse's Tool for Discussing End of Life

A few weeks ago, I had the opportunity to present at my hospital's ethics committee on the topic of legacy letters. Although this tool–designed to help patients and their families to...

CPX-351 Gets Approval to Treat Some AML

The FDA has approved CPX-351 (Vyxeos), a fixed-combination of daunorubicin and cytarabine, for adult patients with newly diagnosed therapy-related acute myeloid leukemia (t-AML) or AML with myelod...

A Clear and Present Danger: Awareness, Vigilance Remain Key to Safe Chemotherapy Handling

Christopher R. Friese, PHD, RN, AOCN, FAAN It has been nearly a decade since the National Institute on Occupational Safety and Health (NIOSH) issued its seminal 2004 Alert warning healthc...

Longitudinal Study Finds No Increased Risk of Breast Cancer From IVF

Many risk factors for breast cancer have been identified. One suspected risk factor is in vitro fertilization (IVF) treatment; however, several studies have been inconclusive because of limited fol...

External Resources

MJH Associates
American Journal of Managed Care
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
OncNurse Resources

Continuing Education
Web Exclusives

About Us
Advisory Board
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.